Thursday, 8 October 2026 Every NSE & BSE announcement, by company
ALFA Filings Every announcement, straight from the exchange

Kopran Ltd

NSE: KOPRAN · BSE: 524280 · Pharmaceuticals & Biotechnology · 28 announcements

Share price
₹276.50
Market cap
₹1,336 Cr
Revenue (annual)
₹681.4 Cr
Net profit (annual)
₹25.73 Cr
P/E (TTM)
53.5×Sector 47.3×
Promoter holding
44.42%+0.00% QoQ
FII holding
0.51%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

16:52 IST BSE
Annual General Meeting

Kopran Annual General Meeting

Kopran Ltd held its 67th Annual General Meeting on August 18, 2026, where all items were passed. Voting results and the Scrutinizer's Report were submitted.

16:21 IST NSE
Annual General Meeting

Kopran Annual General Meeting

Kopran Limited announced an NCLT-convened meeting on June 3, 2026, to approve the amalgamation of Kopran Laboratories Limited into the company. The merger will increase promoter shareholding from 44.43% to 55.33%. This consolidation aims to streamline the group structure and enhance operational efficiencies in the pharmaceutical and healthcare segments.